CS20AT04

· Corestemchemon, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CS20AT04, covering 2021-04-08 to 2025-01-10. Get the full timeline:

Most recent: Clinical Trial Update: Long-term Follow-up for Evaluating the Safety of CS20AT04 in Subject with Lupus Nephritis